Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ward Blenkinsop & Co. was a prominent British pharmaceutical and fine chemical manufacturer founded in 1939. The company became a critical supplier of medicinal chemicals during World War II, specifically specializing in the production of sulfonamide antibiotics such as sulphadiazine. Beyond anti-infectives, the firm was a pioneer in the development of ultraviolet absorbers, marketing the well-known sunscreen agent Uvistat (mexenone). Headquartered in Wembley with significant manufacturing operations in Widnes, the company maintained a strong reputation for complex organic synthesis. In 1984, Ward Blenkinsop was acquired by the Harrisons & Crosfield group, which eventually transitioned into Elementis. Today, the company's legacy remains part of the history of the UK's mid-century industrial chemistry and pharmaceutical sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ward Blenkinsop & Co..